2026 Q1 Portfolio Activity
In 2026 Q1, PSP Research LLC maintained a portfolio of 106 distinct positions. The most significant new addition was SPDR SERIES TRUST, now representing 25.75% of the total fund value. They heavily accumulated shares in INHIBRX BIOSCIENCES INC, increasing the position by 8.4%. Conversely, PSP Research LLC completely exited their position in TRAVERE THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
106
Quarter
2026 Q1
Top Holding
SGOV (49.9%)
Top 10 Concentration
81.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 106
PSP Research LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SGOV
ISHARES TR
|
Bond/Debt | 49.86% | 61.41% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
700,000 | $70,462,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
XBI
SPDR SERIES TRU...
|
Unknown | 25.75% | — |
#2
Prev: #—
|
9.0 |
—
|
284,900 | — |
NEW
|
284,900 | $36,390,277 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
SERA
SERA PROGNOSTIC...
|
Healthcare | 3.44% | — |
#3
Prev: #—
|
5.9 |
—
|
2,396,685 | — |
NEW
|
2,396,685 | $4,865,271 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.47% | — |
#4
Prev: #—
|
4.2 |
—
|
34,800 | — |
NEW
|
34,800 | $657,720 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 0.43% | 0.50% |
#5
1
Prev: #4
|
0.7 |
—
|
-5,853 | -26.8% |
P
S
|
16,000 | $612,800 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.40% | 0.48% |
#6
4
Prev: #10
|
0.7 |
—
|
-79 | -3.1% |
P
S
|
2,500 | $571,825 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.40% | 0.50% |
#7
2
Prev: #5
|
0.7 |
—
|
-511 | -2.5% |
P
S
|
20,000 | $565,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.39% | 0.46% |
#8
39
Prev: #47
|
0.7 |
—
|
-13 | -0.2% |
P
S
|
8,300 | $547,053 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 0.37% | 0.47% |
#9
25
Prev: #34
|
0.1 |
—
|
-2,826 | -20.4% |
P
S
|
11,000 | $527,670 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 0.37% | 0.43% |
#10
67
Prev: #77
|
0.6 |
—
|
-48 | -0.8% |
P
S
|
6,300 | $524,727 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
HALO
HALOZYME THERAP...
|
Healthcare | 0.37% | 0.47% |
#11
11
Prev: #22
|
1.1 |
—
|
no change | no change |
P
S
|
8,026 | $518,720 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
EXEL
EXELIXIS INC
|
Healthcare | 0.36% | 0.46% |
#12
47
Prev: #59
|
1.1 |
—
|
no change | no change |
P
S
|
11,948 | $512,450 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.36% | — |
#13
Prev: #—
|
3.6 |
—
|
8,000 | — |
NEW
|
8,000 | $511,520 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.36% | 0.47% |
#14
11
Prev: #25
|
1.1 |
—
|
no change | no change |
P
S
|
6,800 | $510,612 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.36% | — |
#15
Prev: #—
|
3.6 |
—
|
15,000 | — |
NEW
|
15,000 | $507,450 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.36% | 0.46% |
#16
28
Prev: #44
|
0.6 |
—
|
114 | 3.1% |
P
S
|
3,848 | $506,936 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
INCY
INCYTE CORP
|
Healthcare | 0.35% | 0.46% |
#17
29
Prev: #46
|
0.6 |
—
|
-50 | -0.9% |
P
S
|
5,300 | $498,836 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.35% | 0.47% |
#18
19
Prev: #37
|
2.1 |
—
|
481 | 7.4% |
P
S
|
7,000 | $491,050 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.35% | 0.45% |
#19
50
Prev: #69
|
0.6 |
—
|
286 | 1.9% |
P
S
|
15,000 | $488,100 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.34% | 0.46% |
#20
38
Prev: #58
|
2.1 |
—
|
147 | 11.2% |
P
S
|
1,465 | $484,725 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 0.34% | 0.51% |
#21
19
Prev: #2
|
0.1 |
—
|
-482 | -24.3% |
P
S
|
1,500 | $483,285 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.34% | — |
#22
Prev: #—
|
3.6 |
—
|
2,845 | — |
NEW
|
2,845 | $480,862 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 0.34% | 0.46% |
#23
38
Prev: #61
|
0.6 |
—
|
80 | 0.5% |
P
S
|
15,000 | $480,150 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.34% | — |
#24
Prev: #—
|
3.6 |
—
|
80,000 | — |
NEW
|
80,000 | $479,200 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.34% | 0.45% |
#25
45
Prev: #70
|
0.6 |
—
|
-1,105 | -5.4% |
P
S
|
19,200 | $476,928 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.33% | 0.46% |
#26
17
Prev: #43
|
0.6 |
—
|
11 | 1.7% |
P
S
|
641 | $468,090 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.33% | 0.45% |
#27
40
Prev: #67
|
0.6 |
—
|
-4,716 | -19.1% |
P
S
|
20,000 | $467,200 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 0.33% | 0.44% |
#28
46
Prev: #74
|
2.1 |
—
|
538 | 8.4% |
P
S
|
6,927 | $465,702 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.33% | 0.48% |
#29
12
Prev: #17
|
2.1 |
—
|
984 | 5.3% |
P
S
|
19,700 | $464,132 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.33% | — |
#30
Prev: #—
|
3.6 |
—
|
22,100 | — |
NEW
|
22,100 | $462,995 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 0.33% | 0.47% |
#31
10
Prev: #21
|
0.1 |
—
|
-1,854 | -27.0% |
P
S
|
5,000 | $461,900 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.33% | 0.41% |
#32
48
Prev: #80
|
0.6 |
—
|
-1,233 | -9.3% |
P
S
|
12,000 | $461,880 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.33% | — |
#33
Prev: #—
|
3.6 |
—
|
28,000 | — |
NEW
|
28,000 | $460,600 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.32% | 0.44% |
#34
42
Prev: #76
|
0.6 |
—
|
717 | 5.0% |
P
S
|
15,141 | $456,501 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
CRSP
CRISPR THERAPEU...
|
Healthcare | 0.32% | 0.44% |
#35
40
Prev: #75
|
0.6 |
—
|
-80 | -0.8% |
P
S
|
9,500 | $451,915 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.32% | 0.48% |
#36
21
Prev: #15
|
0.6 |
—
|
-1,140 | -16.0% |
P
S
|
6,000 | $445,560 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.31% | 0.48% |
#37
21
Prev: #16
|
0.6 |
—
|
-13 | -0.0% |
P
S
|
28,700 | $444,850 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
AUPH
AURINIA PHARMAC...
|
Healthcare | 0.31% | 0.47% |
#38
18
Prev: #20
|
0.6 |
—
|
-3,953 | -11.6% |
P
S
|
30,000 | $444,600 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.31% | 0.46% |
#39
10
Prev: #49
|
1.1 |
—
|
no change | no change |
P
S
|
19,766 | $439,991 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 0.31% | 0.46% |
#40
1
Prev: #39
|
0.1 |
—
|
-3,506 | -20.0% |
P
S
|
14,000 | $438,060 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 0.31% | 0.47% |
#41
22
Prev: #19
|
0.1 |
—
|
-5,245 | -20.8% |
P
S
|
20,000 | $437,400 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 0.31% | 0.46% |
#42
21
Prev: #63
|
0.1 |
—
|
-3,655 | -28.9% |
P
S
|
9,000 | $433,350 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 0.31% | 0.46% |
#43
3
Prev: #40
|
0.1 |
—
|
-4,807 | -27.0% |
P
S
|
13,000 | $431,860 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 0.30% | 0.46% |
#44
12
Prev: #56
|
0.1 |
—
|
-7,725 | -60.7% |
P
S
|
5,000 | $419,600 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 0.29% | 0.48% |
#45
38
Prev: #7
|
0.1 |
—
|
-7,368 | -36.2% |
P
S
|
13,000 | $412,360 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 0.29% | 0.47% |
#46
18
Prev: #28
|
0.6 |
—
|
-1,046 | -14.8% |
P
S
|
6,000 | $408,780 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.28% | 0.44% |
#47
26
Prev: #73
|
0.6 |
—
|
4 | 0.0% |
P
S
|
10,000 | $402,300 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.28% | 0.47% |
#48
16
Prev: #32
|
1.1 |
—
|
no change | no change |
P
S
|
14,283 | $400,067 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.28% | 0.46% |
#49
4
Prev: #53
|
0.6 |
—
|
-316 | -2.8% |
P
S
|
11,000 | $399,520 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-17 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 0.28% | — |
#50
Prev: #—
|
3.6 |
—
|
71,000 | — |
NEW
|
71,000 | $392,630 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-17 |
Showing 1-50 of 106 holdings